Usefulness of estimated glucose disposal rate in detecting heart failure: results from national health and nutrition examination survey 1999-2018

被引:2
作者
Zhang, Daoliang [1 ]
Shi, Wenrui [2 ]
An, Tao [3 ]
Li, Chao [1 ]
Ding, Zhaohui [1 ]
Zhang, Jian [1 ,3 ]
机构
[1] Chinese Acad Med Sci, Fuwai Shenzhen Hosp, Dept Cardiol, 12 Langshan Rd,Xili St, Shenzhen, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Cardiol, 180 Fenglin Rd, Shanghai, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Heart Failure Ctr,State Key Lab Cardiovasc Dis, Beijing, Peoples R China
关键词
Epidemiology; Heart failure; Insulin resistance; Estimated glucose disposal rate; General population; HOMEOSTASIS MODEL ASSESSMENT; INSULIN-RESISTANCE; ASSOCIATION;
D O I
10.1186/s13098-024-01402-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Estimated glucose disposal rate (eGDR) is a novel, clinically available, and cost-effective surrogate of insulin resistance. The current study aimed to assess the association between eGDR and prevalent heart failure (HF), and further evaluate the value of eGDR in detecting prevalent HF in a general population. Methods 25,450 subjects from the National Health and Nutrition Examination Survey 1999-2018 were included. HF was recorded according to the subjects' reports. Logistic regression was employed to analyze the association between eGDR and HF, the results were summarized as Per standard deviation (SD) change. Then, subgroup analysis tested whether the main result from logistic regression was robust in several conventional subpopulations. Finally, receiver-operating characteristic curve (ROC) and reclassification analysis were utilized to evaluate the potential value of eGDR in improving the detection of prevalent HF. Results The prevalence of reported HF was 2.96% (753 subjects). After adjusting demographic, laboratory, anthropometric, and medical history data, each SD increment of eGDR could result in a 43.3% (P < 0.001) risk reduction for prevalent HF. In the quartile analysis, the top quartile had a 31.1% (P < 0.001) risk of prevalent HF compared to the bottom quartile in the full model. Smooth curve fitting demonstrated that the association was linear in the whole range of eGDR (P for non-linearity = 0.313). Subgroup analysis revealed that the association was robust in age, sex, race, diabetes, and hypertension subgroups (All P for interaction > 0.05). Additionally, ROC analysis displayed a significant improvement in the detection of prevalent HF (0.869 vs. 0.873, P = 0.008); reclassification analysis also confirmed the improvement from eGDR (All P < 0.001). Conclusion Our study indicates that eGDR, a costless surrogate of insulin resistance, may have a linear and robust association with the prevalent HF. Furthermore, our findings implicate the potential value of eGDR in refining the detection of prevalent HF in the general population.
引用
收藏
页数:10
相关论文
共 36 条
  • [1] Ahsan M, 2018, PAK J PHARM SCI, V31, P719
  • [2] Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI [10.2337/dc12-s011, 10.2337/dc13-S067, 10.2337/dc14-S081, 10.2337/dc10-S011, 10.2337/dc10-S062, 10.2337/dc13-S011, 10.2337/dc11-S011, 10.2337/dc11-S062, 10.2337/dc12-s064]
  • [3] Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America
    Bozkurt, Biykem
    Ahmad, Tariq
    Alexander, Kevin M.
    Baker, William L.
    Bosak, Kelly
    Breathett, Khadijah
    Fonarow, Gregg C.
    Heidenreich, Paul
    Ho, Jennifer E.
    Hsich, Eileen
    Ibrahim, Nasrien E.
    Jones, Lenette M.
    Khan, Sadiya S.
    Khazanie, Prateeti
    Koelling, Todd
    Krumholz, Harlan M.
    Khush, Kiran K.
    Lee, Christopher
    Morris, Alanna A.
    Page, Robert L.
    Pandey, Ambarish
    Piano, Mariann R.
    Stehlik, Josef
    Stevenson, Lynne Warner
    Teerlink, John R.
    Vaduganathan, Muthiah
    Ziaeian, Boback
    [J]. JOURNAL OF CARDIAC FAILURE, 2023, 29 (10) : 1412 - 1451
  • [4] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [5] DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
  • [6] Insulin resistance and incident heart failure: a meta-analysis
    Erqou, Sebhat
    Adler, Amanda I.
    Challa, Azariyas A.
    Fonarow, Gregg C.
    Echouffo-Tcheugui, Justin B.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (06) : 1139 - 1141
  • [7] Insulin Signaling and Heart Failure
    Harper, Shavonn C.
    Brack, Andrew
    MacDonnell, Scott
    Franti, Michael
    Olwin, Bradley B.
    Bailey, Beth A.
    Rudnicki, Michael A.
    Houser, Steven R.
    [J]. CIRCULATION RESEARCH, 2016, 118 (07) : 1143 - 1150
  • [8] Body mass index, estimated glucose disposal rate and vascular complications in type 1 diabetes: Beyond glycated haemoglobin
    Helliwell, Rebecca
    Warnes, Harriet
    Kietsiriroje, Noppadol
    Campbell, Matthew
    Birch, Rebecca
    Pearson, Sam M.
    Ajjan, Ramzi A.
    [J]. DIABETIC MEDICINE, 2021, 38 (05)
  • [9] Insulin resistance, cardiovascular stiffening and cardiovascular disease
    Hill, Michael A.
    Yang, Yan
    Zhang, Liping
    Sun, Zhe
    Jia, Guanghong
    Parrish, Alan R.
    Sowers, James R.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 119
  • [10] Metabolic, structural and biochemical changes in diabetes and the development of heart failure
    Ho, Kim L.
    Karwi, Qutuba G.
    Connolly, David
    Pherwani, Simran
    Ketema, Ezra B.
    Ussher, John R.
    Lopaschuk, Gary D.
    [J]. DIABETOLOGIA, 2022, 65 (03) : 411 - 423